Kavar Capital Partners Group’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.97M Sell
18,858
-99
-0.5% -$21.2K 0.49% 48
2026
Q1
$4.19M Sell
18,957
-350
-2% -$85.6K 0.53% 50
2025
Q4
$4.89M Sell
19,307
-225
-1% -$56.5K 0.67% 39
2025
Q3
$4.83M Sell
19,532
-356
-2% -$85.2K 0.64% 43
2025
Q2
$4.78M Sell
19,888
-1,300
-6% -$303K 0.69% 46
2025
Q1
$4.8M Sell
21,188
-1,379
-6% -$303K 0.8% 40
2024
Q4
$4.64M Buy
22,567
+150
+0.7% +$32.9K 0.78% 39
2024
Q3
$5.44M Sell
22,417
-600
-3% -$140K 0.86% 35
2024
Q2
$5.05M Sell
23,017
-527
-2% -$114K 0.91% 33
2024
Q1
$5.29M Sell
23,544
-24,294
-51% -$5.48M 0.98% 32
2023
Q4
$10.5M Buy
47,838
+23,344
+95% +$4.94M 1.18% 28
2023
Q3
$5.37M Sell
24,494
-643
-3% -$145K 1.17% 27
2023
Q2
$5.66M Sell
25,137
-906
-3% -$181K 1.21% 26
2023
Q1
$4.98M Sell
26,043
-867
-3% -$168K 1.08% 32
2022
Q4
$4.97M Buy
26,910
+50
+0.2% +$8.79K 1.15% 29
2022
Q3
$4.47M Buy
26,860
+2,000
+8% +$407K 1.14% 28
2022
Q2
$5.13M Sell
24,860
-900
-3% -$203K 1.19% 26
2022
Q1
$6.23M Sell
25,760
-157
-0.6% -$36.4K 1.35% 20
2021
Q4
$6.31M Buy
25,917
+95
+0.4% +$21.7K 1.31% 22
2021
Q3
$5.28M Sell
25,822
-160
-0.6% -$34.2K 1.2% 26
2021
Q2
$5.36M Buy
25,982
+139
+0.5% +$28K 1.29% 25
2021
Q1
$4.92M Buy
25,843
+2,880
+13% +$534K 1.33% 24
2020
Q4
$4.35M Buy
22,963
+825
+4% +$154K 1.25% 24
2020
Q3
$3.9M Sell
22,138
-125
-0.6% -$20K 1.32% 22
2020
Q2
$3.42M Sell
22,263
-962
-4% -$147K 1.31% 24
2020
Q1
$3.25M Sell
23,225
-800
-3% -$120K 1.56% 20
2019
Q4
$3.66M Sell
24,025
-800
-3% -$117K 1.36% 24
2019
Q3
$3.59M Hold
24,825
1.4% 22
2019
Q2
$3.7M Buy
24,825
+650
+3% +$86.8K 1.45% 19
2019
Q1
$3.1M Hold
24,175
1.38% 21
2018
Q4
$2.58M Sell
24,175
-500
-2% -$55.8K 1.39% 24
2018
Q3
$2.82M Buy
+24,675
New +$2.79M 1.4% 24
2015
Q2
Sell
-18,500
Closed -$1.3M 537
2015
Q1
$1.3M Buy
+18,500
New +$1.22M 1.11% 42

Other funds holding STE

Kavar Capital Partners Group's STE Position: Q2 2026 in Review

Kavar Capital Partners Group reduced its Steris (STE) stake by 0.52% in Q2 2026, selling an estimated $21.2K and leaving 18,858 shares worth $3.97M. The position accounts for 0.49% of the portfolio, ranked #48.

Kavar Capital Partners Group first reported a position in STE in Q1 2015 and has held it in 33 quarters since. The position peaked at $10.5M in Q4 2023. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Kavar Capital Partners Group held 18,858 shares of Steris worth $3.97M as of Q2 2026.
  • Kavar Capital Partners Group sold 99 Steris shares in Q2 2026, an estimated $21.2K.
  • Steris made up 0.49% of Kavar Capital Partners Group's portfolio in Q2 2026, its #48 holding.
  • Kavar Capital Partners Group first reported a position in Steris in Q1 2015 and has held it in 33 quarters since.
  • Kavar Capital Partners Group's Steris position peaked at $10.5M in Q4 2023.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Kavar Capital Partners Group's 13F filing for Q2 2026, filed 20 Jul 2026.